Trial Profile
A retrospective cohort study to evaluate the efficacy of Sofosbuvir in liver transplant patients undergoing treatment for hepatitis C virus infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 26 Feb 2016 New trial record